Galmed Pharmaceuticals is a biotechnology business based in the US. Galmed Pharmaceuticals shares (GLMD) are listed on the NASDAQ and all prices are listed in US Dollars. Galmed Pharmaceuticals employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Galmed Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – GLMD. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Galmed Pharmaceuticals stock price (NASDAQ: GLMD)
Use our graph to track the performance of GLMD stocks over time.Galmed Pharmaceuticals shares at a glance
Latest market close | $0.67 |
---|---|
52-week range | $0.29 - $1.84 |
50-day moving average | $0.48 |
200-day moving average | $0.58 |
Wall St. target price | $1.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.19 |
Buy Galmed Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Galmed Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Galmed Pharmaceuticals price performance over time
Historical closes compared with the close of $0.671 from 2023-01-26
1 week (2023-01-20) | -10.65% |
---|---|
1 month (2022-12-27) | 24.26% |
3 months (2022-10-27) | 72.05% |
6 months (2022-07-27) | 31.57% |
1 year (2022-01-27) | -51.73% |
---|---|
2 years (2021-01-27) | -81.31% |
3 years (2020-01-27) | 5.61 |
5 years (2018-01-26) | 10.94 |
Galmed Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -43.53% |
Return on equity TTM | -84.9% |
Profit margin | 0% |
Book value | $0.63 |
Market capitalisation | $17.4 million |
TTM: trailing 12 months
Galmed Pharmaceuticals share dividends
We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.
Galmed Pharmaceuticals share price volatility
Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $0.29 up to $1.838. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 1.098. This would suggest that Galmed Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Galmed Pharmaceuticals overview
Galmed Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co. , Ltd.
Frequently asked questions
What percentage of Galmed Pharmaceuticals is owned by insiders or institutions?Currently 13.875% of Galmed Pharmaceuticals shares are held by insiders and 11.419% by institutions. How many people work for Galmed Pharmaceuticals?
Latest data suggests 19 work at Galmed Pharmaceuticals. When does the fiscal year end for Galmed Pharmaceuticals?
Galmed Pharmaceuticals's fiscal year ends in December. Where is Galmed Pharmaceuticals based?
Galmed Pharmaceuticals's address is: 16 Tiomkin Street, Tel Aviv, Israel, 6578317 What is Galmed Pharmaceuticals's ISIN number?
Galmed Pharmaceuticals's international securities identification number is: IL0011313900 What is Galmed Pharmaceuticals's CUSIP number?
Galmed Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: M47238106
More guides on Finder
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
-
Best international stock brokers for 2023
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
Ask an Expert